Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences.
Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.
Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions.
Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles.
A network-based meta-analysis for characterizing the genetic landscape of human aging.
Do cemeteries emit drugs? A case study from southern Germany.
Design of a tripartite network for the prediction of drug targets.
Chemoinformatics: a perspective from an academic setting in Latin America.
Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments.
Atropisomerism in medicinal chemistry: challenges and opportunities.